Abstract:
PURPOSE: A composition containing sulfuretin is provided to prevent or treat type 1 diabetes and to prevent side effects of the diabetes. CONSTITUTION: A composition for preventing and treating type 1 diabetes contains sulfuretin, isolated from Rhus verniciflura, as an active ingredient. A NF-kappaB inhibitor contains sulfuretin, isolated and purified from Rhus verniciflura, as an active ingredient. An iNOS expression inhibitor contains sulfurein as an active ingredient. A health food for preventing diabetes contains sulfuretin as an active ingredient. The composition additionally contains pharmaceutically or nutritionally acceptable carrier, excipient, diluent, or accessory ingredients.
Abstract:
PURPOSE: A composition containing sulfuretin isolated and purified Rhus verniciflua is provided to reduce airway inflammatory response and to treat asthma. CONSTITUTION: A composition for preventing and treating bronchial asthma contains sulfuretin isolated from Rhus verniciflua as an active ingredient. An inhibitor of cytokine immune response contains sulfuretin as an active ingredient. An NF-kappaB activity inhibitor contains sulfuretin as an active ingredient. A composition for preventing and treating airway hyperreactivity contains sulfuretin as an active ingredient.
Abstract:
PURPOSE: A skin whitening composition containing Oenothera odorata seed oil saponificated compounds is provided to suppress the expression of Trp1, Trp2, and MITF gene. CONSTITUTION: A skin whitening cosmetic composition contains Oenothera odorata seed oil saponificated compounds. The Oenothera odorata seed oil saponificated compound is obtained using alkali metal hydroxide of NaOH, LiOH, or KOH. The composition is manufactured in the form of skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, massage cream, moisture cream, essence, nutrition essence, pack, soap, shampoo, cleansing foam, and cleansing cream. A pharmaceutical composition for preventing and treating pigmentation contains Oenothera odorata seed oil saponificated compounds as an active ingredient. The composition is manufactured in the form of cream, gel, patch, spray, ointment, lotion, liniment, pasta, or cataplasma.
Abstract:
본 발명은 감송향 추출물을 유효성분으로 포함하는 제1형 당뇨병 예방 및 치료용 조성물, 및 이를 포함하는 건강식품에 관한 것이다. 상기 감송향 추출물을 제1형 당뇨병 질환에 이용함으로서, 지속적인 인슐린 투여가 필요한 제1형 당뇨병을 예방 또는 치료할 수 있다는 장점과, 감송향과 같은 천연물질을 사용함으로써, 부작용 우려를 피할 수 있다. 그러므로, 제1형 당뇨병을 예방 또는 치료함으로써, 환자의 건강에 기여할 수 있으며, 당뇨병과 관련된 산업에 유용하게 사용될 수 있다.
Abstract:
PURPOSE: A therapeutic agent for anti-diabetes containing Fructus Xanthii extract is provided to suppress NF-kappa B activation and to protect cell by nitric oxide reduction. CONSTITUTION: A pharmaceutical composition for suppressing islet break after pancreas or pancreatic duct transplantation surgery contains 0.1-99 weight% of Fructus Xanthii extract. The composition further contains carrier, excipient or diluents. The composition is used in the form of powder, tablet, capsule, suspension, syrup, dry syrup or aerosol, suppository, or external use.
tokoronis ) 추출물을 유효성분으로 하는 항비만 조성물에 관한 것으로, 고지방식이에 의한 체중증가를 억제할 수 있다. 구체적으로는 고지방 식이군에 비해 추출물을 투여한 결과 혈중 triglyceride, LDL-cholesterol, total cholesterol을 낮추고, 반대로 심혈관 질환을 억제하는 HDL-cholesterol 수치는 높임으로써 항비만 치료제로서 제공할 수 있다. 비해 추출물, 비만, 고지방식이
Abstract:
PURPOSE: An anti-diabetic composition is provided to suppress blood sugar increase and reduction of insulin secretion and to effectively apply for suppressing type I diabetes. CONSTITUTION: An anti-diabetic composition contains Acanthopanax Senticosus extract as an active ingredient. The Acanthopanax Senticosus extract is extract fermentation of which anti-diabetic effect is enhanced. A method for extracting Acanthopanax Senticosus comprises: a step of heating 1kg of Acanthopanax Senticosus in 10L of ethanol at 60-80°C for three hours; a step of filtering the extract and repeating; and a step of filtering the extract and concentrating under 60°C to obtain average 70 Brix of dried extract. A method for fermenting the extract comprises: a step of suspending the dried extract in purified water; a step of sterilizing 1L of suspended extract at high temperature and high pressure and cooling; a step of adding 10ml of Lactobacillus plantarum; and a step of fermenting the mixture at 30-32°C for two weeks.
Abstract:
PURPOSE: A composition containing sulfuretin is provided to prevent or treat type 1 diabetes and to prevent side effects of the diabetes. CONSTITUTION: A composition for preventing and treating type 1 diabetes contains sulfuretin, isolated from Rhus verniciflura, as an active ingredient. A NF-kappaB inhibitor contains sulfuretin, isolated and purified from Rhus verniciflura, as an active ingredient. An iNOS expression inhibitor contains sulfurein as an active ingredient. A health food for preventing diabetes contains sulfuretin as an active ingredient. The composition additionally contains pharmaceutically or nutritionally acceptable carrier, excipient, diluent, or accessory ingredients.
Abstract:
PURPOSE: A composition containing a saponification product of sunflower oil is provided to prevent and treat pigmentary disorder without side effects. CONSTITUTION: A cosmetic composition for skin whitening contains a saponification product of sunflower oil as an active ingredient. The cosmetic composition is manufactured in the form of skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, massage cream, moisture cream, hand cream, essence, pack, soap, shampoo, cleansing foam, or eye shadow. A composition for preventing and treating pigmentary disorder contains 0.001-99.9% of saponification product of sunflower oil. The composition is manufactured in the form of gel, cream, patch, spray, ointment, plaster, lotion, or cataplasma.